Abstract
The number of new drugs entering the U.S. market has declined sharply, while spending by the pharmaceutical industry on research and development has steadily increased, congressional investigators said in a recent report. From 1993 through 2004, pharmaceutical research and development expenses
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
